MCL1 and acute myeloid leukemia: Mcl-1 overexpression only partially rescued the AML cells from venetoclax in combination with voruciclib treatment (Fig. 3d), indicating that downregulation of Mcl-1 was only part of the mechanism of action of the combination treatment.